Hereditary Diffuse Gastric Cancer: A Family Diagnosis and Treatment

  • Clinical Medicine & Research
  • June 2012,
  • cmr.2012.1071;
  • DOI: https://doi.org/10.3121/cmr.2012.1071

Abstract

Hereditary diffuse gastric cancer (HDGC) is a rare cancer representing approximately 2% of all gastric cancers. It is caused by CDH1 gene mutations, inherited in an autosomal dominant fashion, that affect the function of E-cadherin. Approximately 38% of HDGC families have a CDH1 gene mutation. With an estimated 75% penetrance rate, carriers are at high risk for HDGC. We describe the case of a Caucasian male of German-Russian ancestry, carrying a CDH1 gene mutation, who survived for ~18 months after being diagnosed with HDGC. The results of genetic testing undergone by his family members are also reported, along with a review of the current literature. Since surveillance methods for HDGC are ineffective and unreliable, total prophylactic gastrectomy is advised for individuals with the gene mutation. Additionally, a diagnosis of HDGC should lead to genetic evaluation of family members followed by preventative measures.

  • Received December 14, 2011.
  • Revision received March 28, 2012.
  • Revision received April 12, 2012.
  • Accepted April 18, 2012.
Loading
  • Print
  • Download PDF
  • Article Alerts
  • Email Article
  • Citation Tools
  • Share
  • Bookmark this Article